MRP14 (S100A9) protein interacts with Alzheimer beta-amyloid peptide and induces its fibrillization

57Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

Abstract

Increasing evidence supports the contribution of local inflammation to the development of Alzheimer's disease (AD) pathology, although the precise mechanisms are not clear. In this study, we demonstrate that the pro-inflammatory protein S100A9 interacts with the Aβ1-40 peptide and promotes the formation of fibrillar β-amyloid structures. This interaction also results in reduced S100A9 cytotoxicity by the binding of S100A9 toxic species to Aβ1-40 amyloid structures. These results suggest that secretion of S100A9 during inflammation promotes the formation of amyloid plaques. By acting as a sink for toxic species, plaque formation may be the result of a protective response within the brain of AD patients, in part mediated by S100A9. © 2012 Zhang et al.

Cite

CITATION STYLE

APA

Zhang, C., Liu, Y., Gilthorpe, J., & van der Maarel, J. R. C. (2012). MRP14 (S100A9) protein interacts with Alzheimer beta-amyloid peptide and induces its fibrillization. PLoS ONE, 7(3). https://doi.org/10.1371/journal.pone.0032953

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free